Comparison of clinical effectiveness of ketorolac and Triamcinolone injection in patients with moderate to severe carpal tunnel syndrome

Phase 2

• Conditions: CARPAL TUNNEL SYNDROME.; Carpal tunnel syndrome; G56.0

• Registration Number: IRCT20190326043118N1
• Lead Sponsor: Vice chancellor for research, Tabriz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 October 2019

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 45

Inclusion Criteria

Proof of Carpal Tunnel Syndrome Moderate with STEVENS Electrodiogenesis Criteria
CMAP latency>4.2msec
SNAP latency>3.0msec
SNAP latency>3.0msec+low amplitude SNAP
NCV across wrist<40m/sec
CMAP Amplitude <4mv with SNAPs amplitude <12uv without symptoms of degeneration (fib / psw) in tension in Nidal EMG

Exclusion Criteria

Symptoms of atrophy of the tenar
Contraindication of corticosteroid injection such as corticosteroid hypersensitivity and injection site infection
Treatment of carpal tunnel syndrome with surgery or corticosteroid injection over the past 6 months
Traumatic or neoplastic origin of symptoms
No consent for injection
Symptoms of denervation in electromyography suggestive of severe axonal injury
Symptoms of active cervical radiculopathy in electromyography or cervical disc protrusion in MRI

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Total score of Carpal Tunnel Syndrome Questionnaire Boston To measure severity of symptoms and dysfunction. Timepoint: Before intervention and 3 months later. Method of measurement: boston carpal tunnel questionnaire.

Secondary Outcome Measures

Name	Time	Method
Hand power. Timepoint: Before intervention and 3 months later. Method of measurement: hand dynamometer.